Generic Injectables Market to Witness Growth Acceleration by 2028

The global generic injectables market is anticipated to grow at a significant CAGR during the forecast period (2021-2027).  The major factors that are expected to accelerate the growth of the market during the forecast period include the advantages offered by generic injectables and favorable governments initiatives are supporting the growth of the market. Moreover, an increase in drug shortages, especially in the US, along with patent expiry of a number of blockbuster drugs, aging population, and rising prevalence of chronic as well as lifestyle diseases, are some of the other factors that are anticipated to boost the growth of the market during the forecast period. Injectable usually refers to a drug delivery system and acts as an alternative to oral drugs. The generic injectable is a pharmaceutical drug with the same active ingredient as the innovator drug and is equivalent to it in terms of route of administration, intended use, performance, strength, dosage, and side effects.

To Request a Sample of our Report on Global Generic Injectables Market:  https://www.omrglobal.com/request-sample/generic-injectables-market

The manufacture of generic injectables is feasible only on the expiration of the patent of innovator injectables. Generic injectables are bio-equivalent of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have a similar active ingredient, dosage, strength, quality, and form. Although the manufacturing of generic injectables is complex, their R&D cycle is cost-effective and shorter. Unlike branded drug manufacturers who spend millions of dollars on R&D and marketing, generic drug manufacturers do not require such investments. Moreover, the number of competitors in the generic injectables market is lower as compared to oral generics, resulting in limited price erosion and significantly higher profit margins.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: Pfizer Inc., AstraZeneca plc, and Hikma Pharmaceuticals plc, among others.

A full Report of Global Generic Injectables Market is Available @  https://www.omrglobal.com/industry-reports/generic-injectables-market

Global Generic Injectables Market Report by Segment

By Therapeutic Area

  • Oncology
  • Anesthesia
  • Anti-Infectives
  • Parenteral Nutrition
  • CVD

By Distribution Channel

  • Hospitals
  • Retail Pharmacy

Global Generic Injectables Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan
  • South Korea
  • Rest of APAC

Rest of the World

Reasons to buy from us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/generic-injectables-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404